Mark D. Aaron
Fondatore presso CellExSys, Inc.
Posizioni attive di Mark D. Aaron
Società | Posizione | Inizio | Fine |
---|---|---|---|
CellExSys, Inc.
CellExSys, Inc. BiotechnologyHealth Technology Part of Calyx Ventures, Inc., CellExSys, Inc. is a company that provides research and development of intellectual property in the area of cell therapy and the generation of antigen-specific T-lymphocytes. The company is based in Seattle, WA. The company was founded by David M. Schubert, Mark D. Aaron. CellExSys was acquired by Chromos Molecular Systems, Inc. from AmpliPhi Biosciences Corp. on July 28, 2004 for $3.09 million. | Fondatore | 31/10/2011 | - |
Membro del Comitato di Investimento | 31/10/2011 | 31/10/2011 | |
Corporate Officer/Principal | 01/01/2001 | 31/10/2011 |
Storia della carriera di Mark D. Aaron
Precedenti posizioni note di Mark D. Aaron
Società | Posizione | Inizio | Fine |
---|---|---|---|
Weiser LLP
Weiser LLP Miscellaneous Commercial ServicesCommercial Services Weiser LLP provides accounting, auditing, tax, management information and financial advisory services to business owners and high net worth individuals. The company is located in New York, NY. | Corporate Officer/Principal | - | 08/04/2010 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/11/1997 | 01/12/2000 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Vendite & Marketing | - | - |
Formazione di Mark D. Aaron
The Pennsylvania State University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 3 |
Sales & Marketing | 1 |
Founder | 1 |
Settori
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Weiser LLP
Weiser LLP Miscellaneous Commercial ServicesCommercial Services Weiser LLP provides accounting, auditing, tax, management information and financial advisory services to business owners and high net worth individuals. The company is located in New York, NY. | Commercial Services |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
CellExSys, Inc.
CellExSys, Inc. BiotechnologyHealth Technology Part of Calyx Ventures, Inc., CellExSys, Inc. is a company that provides research and development of intellectual property in the area of cell therapy and the generation of antigen-specific T-lymphocytes. The company is based in Seattle, WA. The company was founded by David M. Schubert, Mark D. Aaron. CellExSys was acquired by Chromos Molecular Systems, Inc. from AmpliPhi Biosciences Corp. on July 28, 2004 for $3.09 million. | Health Technology |
- Borsa valori
- Insiders
- Mark D. Aaron
- Esperienza